HYQ Trademark

Trademark Overview

On Friday, September 11, 2009, a trademark application was filed for HYQ with the United States Patent and Trademark Office. The USPTO has given the HYQ trademark a serial number of 77824876. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, June 17, 2011. This trademark is owned by Baxter International Inc.. The HYQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical fluid infusion products such as immunoglobulin to be administered subcutaneously with the aid of enzymes
hyq

General Information

Serial Number77824876
Word MarkHYQ
Filing DateFriday, September 11, 2009
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, June 17, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical fluid infusion products such as immunoglobulin to be administered subcutaneously with the aid of enzymes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 15, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaxter International Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Friday, June 17, 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, June 17, 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, May 6, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 6, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 19, 2010NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, November 19, 2010FINAL REFUSAL E-MAILED
Friday, November 19, 2010FINAL REFUSAL WRITTEN
Friday, November 19, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 19, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 19, 2010ASSIGNED TO LIE
Wednesday, November 3, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 3, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 3, 2010NON-FINAL ACTION E-MAILED
Monday, May 3, 2010NON-FINAL ACTION WRITTEN
Thursday, April 29, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 28, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 28, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 30, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 30, 2009NON-FINAL ACTION E-MAILED
Friday, October 30, 2009NON-FINAL ACTION WRITTEN
Friday, October 30, 2009ASSIGNED TO EXAMINER
Tuesday, September 15, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 15, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

administered subcutaneously enzymes immunoglobulin such fluid infusion products pharmaceutical